Holen Sie sich die Stockscreener-App
0.4687
3.00%
-0.0145
Handel nachbörslich:
.47
0.0013
+0.28%
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth SA explores US growth opportunities as diagnostics demand evolves - AD HOC NEWS
Price to book forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Mdxhealth receives NASDAQ non-compliance notice after $1 bid price breach - MSN
Mdxhealth Faces Nasdaq Compliance Deadline After Minimum Bid Price Breach - TipRanks
Nasdaq warns mdxhealth (NASDAQ: MDXH) on $1 bid rule, eyes reverse split - Stock Titan
Mdxhealth receives Nasdaq minimum bid price deficiency notice - Investing.com
MDxHealth Gets Nasdaq Non-Compliance Notice - marketscreener.com
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Manila Times
Mdxhealth gets 180 days to fix Nasdaq bid-price issue - Stock Titan
MDxHealth Study Backs Prostate Cancer Test - Orange County Business Journal
MDxHealth SA(NasdaqCM: MDXH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Mdxhealth study published in European Urology Oncology - Investing.com
Mdxhealth study published in European Urology Oncology By Investing.com - Investing.com India
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial - The Manila Times
Mdxhealth study finds 92% six-year freedom from failure - Stock Titan
MDxHealth SA(NasdaqCM: MDXH) added to Russell 3000E Value Benchmark - marketscreener.com
MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH) - TradingView
MDxHealth S.A. Actuals & Estimates (SWB:O6C1) - TradingView
MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
MDXH Forecast — Price Target — Prediction for 2027 - TradingView
MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDXH PE Ratio & Valuation, Is MDXH Overvalued - Intellectia AI
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDxHealth StockThursday technical snapshot around key support - AD HOC NEWS
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MDxHealth SA (MDXH) Institutional Confidence - TradingKey
MDxHealth (MDXH) Hovers Near Key Support Level After Marginal DeclineWyckoff Upthrust - newsline.com
· Analyst Forecast - MLQ.ai
MDxHealth (MDXH) Slips 5.7% as Shares Test Key Support at $0.54Ease of Movement - newsline.com
MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant - Stock Titan
MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options - Stock Titan
Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76 - Stock Titan
MDxHealth (MDXH) awards new share options to finance VP - Stock Titan
MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike - Stock Titan
MDxHealth (MDXH) director-linked entity receives 10,000 share options at $0.76 - Stock Titan
MDxHealth (NASDAQ: MDXH) grants CCO John Bellano 333,000 share options - Stock Titan
MDxHealth (MDXH) director granted options on 10,000 shares - Stock Titan
MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV - Stock Titan
MDxHealth (MDXH) Edges Higher as Stock Tests Key Resistance Near $0.80Sentiment Shift - thelegaladvocate.com
MDxHealth (MDXH) VP Brendan O’Connell files initial Form 3 ownership report - Stock Titan
MDXH - Finviz
MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support LevelEnding Diagonal - thelegaladvocate.com
MDxHealth to Shut Down Resolve UTI Business - Orange County Business Journal
MDXHealth Q1 2026 Earnings: EPS Miss Weighs on Shares as Company Navigates Diagnostic MarketEarnings Call Transcript - The Legal Advocate
MDxHealth SA (MDXH) Stock Analysis: -3.98% Loss — Key Levels 2026-05-21Fair Value Gap - Newser
Mdxhealth Refocuses on Prostate Franchise Amid Headwinds - The Globe and Mail
MDxHealth SA (MDXH) Stock Analysis: +4.85% Gain — What to Watch 2026-05-20Upthrust Pattern - Newser
Earnings call transcript: MDxHealth Q1 2026 sees significant stock drop amid earnings miss - Investing.com Canada
MDxHealth SA (MDXH) Slips -1.62%, Testing $0.84 Support 2026-05-18Verified Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Earnings: Miss Sparks ConcernCrowd Trend Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Results Fall Short — EPS $-0.17, Revenue $N/ADividend Cut Risk - Newser
0.50%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):